Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04999644 · ClinicalTrials.gov registry record · Early Phase 1
Reduced Nicotine Cigarette Purchasing Decisions
A Early Phase 1 study of Tobacco Use Disorder, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04999644: Completed Early Phase 1 study of Tobacco Use Disorder, sponsored by Johns Hopkins University.
NCT04999644 is a Early Phase 1 study of Tobacco Use Disorder that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04999644, a Early Phase 1 study of Tobacco Use Disorder, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.
Conditions Studied
Interventions
- DRUG Full Nicotine Cigarettes
- DRUG Reduced Nicotine Cigarettes
- BEHAVIORAL Average Nicotine Expectancy
- BEHAVIORAL Very Low Nicotine Expectancy
Study Locations (1)
Maryland
- Behavioral Pharmacology Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2023-03-29 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04999644
The ClinicalTrials.gov registry entry for NCT04999644 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (91% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Full Nicotine Cigarettes is the first listed.
NCT04999644 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04999644 about?
NCT04999644 is a clinical study titled "Reduced Nicotine Cigarette Purchasing Decisions". The goal of this project is to experimentally evaluate how expectations about reduced-nicotine cigarettes as well as actual nicotine content interact to determine behavioral and subjective response for these novel products.
What is the current status of trial NCT04999644?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 21 participants. The study started on 2022-02-23. Estimated completion is 2023-03-29.
What conditions does trial NCT04999644 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT04999644?
The interventions under investigation include: Full Nicotine Cigarettes (DRUG), Reduced Nicotine Cigarettes (DRUG), Average Nicotine Expectancy (BEHAVIORAL), Very Low Nicotine Expectancy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04999644?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04999644 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
Cannabis-Tobacco Co-Use Treatment Study
RECRUITING · Phase 3
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
RECRUITING · Phase 4
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.